There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Inari Medical Inc. (NARI) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$1.27, or -1.86%, to $66.86. The Inari Medical Inc. has recorded 10,797 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Inari Medical to Present at Upcoming Investor Conferences.
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $68.13 and fluctuated between $68.95 as its day high and $66.00 as its day low. The current market capitalization of Inari Medical Inc. is $3.74B. A total of 0.62 million shares were traded on the day, compared to an average of 779.22K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, NARI has seen 1 BUY and 33 SELL insider trades, representing the acquisition of 6,500 and the disposition of 147,798 shares. Over the last 12 months, there were 35 BUYs and 239 SELLs from insiders. Insiders purchased 2,269,871 shares during that period but sold 903,754.
In the most recent transaction, Hykes Andrew sold 36,676 shares of NARI for 66.11 per share on Aug 16. After the transaction, the President and CEO now owns 475,132 company shares. In a previous transaction on Aug 16, Tu Thomas sold 24,926 shares at 66.11 per share. NARI shares that Chief Medical Officer owns now total 347,997.
Among the insiders who sold shares, Hoffman William disposed of 25,000 shares on Aug 15 at a per-share price of $69.02. This resulted in the Director holding 1,048,055 shares of NARI after the transaction. In another insider transaction, Hill, Mitch C. sold 6,500 shares at $70.47 per share on Aug 14. Company shares held by the Chief Financial Officer now total 171,802.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for NARI in the last 3 months, the mean price target is $85.70 with high estimates of $100.00 and low estimates of $65.00. In terms of 52-week highs and lows, NARI has a high of $83.84 and a low of $52.59.
As of this writing, NARI has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of $0.05 per share and a lower estimate of -$0.07. The company reported an EPS of -$0.04 in the last quarter, which was 82.60% higher than expectations of -$0.23.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NARI’s latest balance sheet shows that the firm has $176.10M in Cash & Short Term Investments as of fiscal 2021. There were $29.21M in debt and $42.51M in liabilities at the time. Its Book Value Per Share was $7.62, while its Total Shareholder’s Equity was $239.21M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NARI is Buy with a score of 4.67.